Valdecoxib and Pain Relief
Author Information
Author(s): David Burns, Lindsay Hill, Michael Essandoh, Tomasz M Jarzembowski, Gregg H Schuler, Piotr K Janicki
Primary Institution: Pennsylvania State College of Medicine and Milton S. Hershey Medical Center
Hypothesis
Selective COX-2 inhibitors significantly attenuate the central component of sensitization, thereby decreasing the area of secondary hyperalgesia induced by our heat/capsaicin pain model.
Conclusion
A single, oral dose of valdecoxib does not attenuate secondary hyperalgesia induced by heat/capsaicin in healthy volunteers.
Supporting Evidence
- Valdecoxib did not significantly change the area of secondary hyperalgesia compared to placebo.
- Pain thresholds for cold and hot stimuli were similar between the valdecoxib and placebo groups.
- The study was conducted in a double-blind manner to ensure unbiased results.
Takeaway
The study tested if a pain medication called valdecoxib could help reduce pain sensitivity, but it didn't work as hoped.
Methodology
A randomized, double-blind, placebo-controlled, crossover trial with 20 healthy volunteers receiving either valdecoxib or placebo.
Potential Biases
No significant bias risks were reported.
Limitations
The study did not include a positive control to demonstrate internal sensitivity of the test.
Participant Demographics
20 healthy adult volunteers (10 men and 10 women).
Statistical Information
P-Value
0.092
Statistical Significance
p > 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website